Helfrich W - Search Results

1

CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitro.

Molema G, Tervaert JW, Kroesen BJ, Helfrich W, Meijer DK, de Leij LF. Molema G, et al. Among authors: helfrich w. Br J Cancer. 2000 Jan;82(2):472-9. doi: 10.1054/bjoc.1999.0945. Br J Cancer. 2000. PMID: 10646907 Free PMC article.

2

Splicing of the VASE exon of neural cell adhesion molecule (NCAM) in human small-cell lung carcinoma (SCLC).

van Duijnhoven HL, Helfrich W, de Leij L, Roebroek AJ, van de Ven WJ, Healey K, Culverwell A, Rossell RJ, Kemshead JT, Patel K. van Duijnhoven HL, et al. Among authors: helfrich w. Int J Cancer. 1992 Jan 2;50(1):118-23. doi: 10.1002/ijc.2910500124. Int J Cancer. 1992. PMID: 1339414

3

Epitope mapping of SCLC-cluster-2 MAbs and generation of antibodies directed against new EGP-2 epitopes.

Helfrich W, Koning PW, The TH, De Leij L. Helfrich W, et al. Int J Cancer Suppl. 1994;8:64-9. doi: 10.1002/ijc.2910570714. Int J Cancer Suppl. 1994. PMID: 7515032

4

Reduction of EGP-2-positive pulmonary metastases by bispecific-antibody-redirected T cells in an immunocompetent rat model.

Kroesen BJ, Helfrich W, Bakker A, Wubbena AS, Bakker H, Kal HB, The TH, de Leij L. Kroesen BJ, et al. Among authors: helfrich w. Int J Cancer. 1995 Jun 9;61(6):812-8. doi: 10.1002/ijc.2910610612. Int J Cancer. 1995. PMID: 7790116

5

Detection of a putative 30-kDa ligand of the cluster-2 antigen.

Helfrich W, Van Geel M, The TH, De Leij L. Helfrich W, et al. Int J Cancer Suppl. 1994;8:70-5. doi: 10.1002/ijc.2910570715. Int J Cancer Suppl. 1994. PMID: 8194899

6

The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity.

Kroesen BJ, Wellenberg GJ, Bakker A, Helfrich W, The TH, de Leij L. Kroesen BJ, et al. Among authors: helfrich w. Br J Cancer. 1996 Mar;73(6):721-7. doi: 10.1038/bjc.1996.127. Br J Cancer. 1996. PMID: 8611371 Free PMC article.

7

A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood.

Helfrich W, ten Poele R, Meersma GJ, Mulder NH, de Vries EG, de Leij L, Smit EF. Helfrich W, et al. Br J Cancer. 1997;76(1):29-35. doi: 10.1038/bjc.1997.331. Br J Cancer. 1997. PMID: 9218728 Free PMC article.

8

Approaches to lung cancer treatment using the CD3 x EGP-2-directed bispecific monoclonal antibody BIS-1.

Kroesen BJ, Nieken J, Sleijfer DT, Molema G, de Vries EG, Groen HJ, Helfrich W, The TH, Mulder NH, de Leij L. Kroesen BJ, et al. Among authors: helfrich w. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):203-6. doi: 10.1007/s002620050433. Cancer Immunol Immunother. 1997. PMID: 9435874 Free PMC article. Clinical Trial.

9

Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas.

Helfrich W, Kroesen BJ, Roovers RC, Westers L, Molema G, Hoogenboom HR, de Leij L. Helfrich W, et al. Int J Cancer. 1998 Apr 13;76(2):232-9. doi: 10.1002/(sici)1097-0215(19980413)76:2<232::aid-ijc11>3.0.co;2-e. Int J Cancer. 1998. PMID: 9537586

10

Analysis of in vitro lymphocyte adhesion and transendothelial migration by fluorescent-beads-based flow cytometric cell counting.

Molema G, Mesander G, Kroesen BJ, Helfrich W, Meijer DK, de Leij LF. Molema G, et al. Among authors: helfrich w. Cytometry. 1998 May 1;32(1):37-43. doi: 10.1002/(sici)1097-0320(19980501)32:1<37::aid-cyto5>3.0.co;2-c. Cytometry. 1998. PMID: 9581622 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters